IceCure Medical Ltd.
Nasdaq · Healthcare · Surgical & Medical Instruments & Apparatus · Caesarea
ICCM chart
What traders are saying about $ICCM
Latest postsIceCure Medical Ltd. news
- Icecure Medical Ltd. Successfully Completes First Cryoablation Treatment in Its Choice Post-Marketing Study for Breast Cancer
www.marketscreener.com ·
- First patient treated in US study of IceCure's ProSense cryoablation for low-risk breast cancer
Pluang ·
- IceCure enrolls first patient in breast cancer cryoablation study
StreetInsider ·
- IceCure Successfully Completes First Cryoablation Treatment in Its ChoICE Post-Marketing Study for Breast Cancer Cryoablation
Yahoo Finance ·
- A breast cancer study treats its first patient by freezing a tumor
Stock Titan ·
- IceCure enrols initial patients for ProSense cryoablation trial in US
medicaldevice-network.com ·
- IceCure Enrolls First Patients in Its FDA-Approved Study for ProSense® Breast Cancer Cryoablation at Two U.S. Sites
Yahoo Finance ·
- IceCure Highlights Clinical Data and Strong Physician Engagement for ProSense® Breast Cancer Cryoablation at EUSOBI 2026
Yahoo Finance ·
- IceCure Expands ProSense® ChoICE Study for Low-Risk Breast Cancer adding Legacy Health in Portland, OR as U.S. Clinical Site
Yahoo Finance ·
- IceCure Secures China NMPA Approval for ProSense Cryoablation System
Yahoo Finance ·
- IceCure Medical Receives Regulatory Approval to Market ProSense® in China
Yahoo Finance ·
- IceCure Signs Exclusive Distribution Agreement for ProSense® Cryoablation Systems in the Netherlands
Yahoo Finance ·
IceCure Medical Ltd. key financials
| USD | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Revenue | $3.4M | $3.3M | $3.2M | $3.1M |
| Net income | -$15.1M | -$15.3M | -$14.7M | -$17.0M |
| Diluted EPS | $0.24 | $0.30 | $0.32 | $0.46 |
| Total assets (year end) | $13.9M | $12.6M | $16.4M | $30.2M |
| Cash and equivalents (year end) | $8.9M | $7.6M | $10.5M | $23.7M |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
- 6-KREPORT OF FOREIGN PRIVATE ISSUER
- 6-KCURRENT REPORT
- 6-KREPORT OF FOREIGN PRIVATE ISSUER
- 6-KCURRENT REPORT
- 6-KREPORT OF FOREIGN PRIVATE ISSUER
- 6-KREPORT OF FOREIGN PRIVATE ISSUER
- 6-KREPORT OF FOREIGN PRIVATE ISSUER
- 6-KREPORT OF FOREIGN PRIVATE ISSUER
- 6-KREPORT OF FOREIGN PRIVATE ISSUER
- 6-KREPORT OF FOREIGN PRIVATE ISSUER
- 6-KCURRENT REPORT
- 6-KREPORT OF FOREIGN PRIVATE ISSUER
About IceCure Medical Ltd.
- Ticker
- ICCM (Nasdaq)
- Industry
- Surgical & Medical Instruments & Apparatus
- Headquarters
- Caesarea
- Incorporated in
- Israel
- Fiscal year end
- December 31
- SEC CIK
- 1584371
Frequently asked questions
What exchange is IceCure Medical Ltd. listed on?
IceCure Medical Ltd. trades on the Nasdaq under the ticker symbol ICCM.
What industry is IceCure Medical Ltd. in?
IceCure Medical Ltd. is classified by the SEC under "Surgical & Medical Instruments & Apparatus", part of the Healthcare sector on StockTweeting.
Where is IceCure Medical Ltd. headquartered?
IceCure Medical Ltd.'s business address on file with the SEC is in Caesarea.
When does IceCure Medical Ltd.'s fiscal year end?
IceCure Medical Ltd.'s fiscal year ends on December 31.
How much revenue did IceCure Medical Ltd. report?
IceCure Medical Ltd. reported $3.4M in revenue for calendar year 2025, according to its SEC filings.